litlas
ログインアカウント作成

Noemı́ Reguart

2002–2025 年に発表

95
論文数
18,100
被引用数
50
h 指数
86
i10 指数

被引用数

Noemı́ Reguart の年別被引用数1971 年: 被引用 1 件1993 年: 被引用 2 件2001 年: 被引用 2 件2002 年: 被引用 4 件2004 年: 被引用 13 件2005 年: 被引用 24 件2006 年: 被引用 48 件2007 年: 被引用 61 件2008 年: 被引用 61 件2009 年: 被引用 55 件2010 年: 被引用 93 件2011 年: 被引用 120 件2012 年: 被引用 123 件2013 年: 被引用 200 件2014 年: 被引用 161 件2015 年: 被引用 202 件2016 年: 被引用 176 件2017 年: 被引用 172 件2018 年: 被引用 213 件2019 年: 被引用 598 件2020 年: 被引用 620 件2021 年: 被引用 687 件2022 年: 被引用 531 件2023 年: 被引用 432 件2024 年: 被引用 782 件2025 年: 被引用 391 件2026 年: 被引用 6 件1972〜1992 年は被引用が無いため表示していません1994〜2000 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,845 件、この内訳の 21.2%中国: 引用元論文 1,346 件、この内訳の 15.5%イタリア: 引用元論文 488 件、この内訳の 5.6%スペイン: 引用元論文 467 件、この内訳の 5.4%日本: 引用元論文 441 件、この内訳の 5.1%イギリス: 引用元論文 384 件、この内訳の 4.4%フランス: 引用元論文 374 件、この内訳の 4.3%ドイツ: 引用元論文 365 件、この内訳の 4.2%韓国: 引用元論文 265 件、この内訳の 3.1%オランダ: 引用元論文 236 件、この内訳の 2.7%カナダ: 引用元論文 230 件、この内訳の 2.6%スイス: 引用元論文 199 件、この内訳の 2.3%
0%21.2%その他 23.6%

機関

分野

  • Medicine73.3%
  • Biochemistry, Genetics and Molecular Biology22.7%
  • Immunology and Microbiology1.6%
  • Engineering0.5%
  • Chemistry0.4%
  • Computer Science0.3%
  • その他1.2%

トピック

  • Lung Cancer Treatments and Mutations17.3%
  • Lung Cancer Research Studies8.3%
  • Cancer Immunotherapy and Biomarkers6.7%
  • Lung Cancer Diagnosis and Treatment6.3%
  • Cancer Genomics and Diagnostics5.1%
  • Colorectal Cancer Treatments and Studies2.2%
  • その他54.1%

共著者

全論文

検索で開く
  1. Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

    著者: Mariano Provencio, Ernest Nadal, J.L. González-Larriba, Alex Martínez‐Martí, Reyes Bernabé, Joaquim Bosch‐Barrera, Joaquín Casal‐Rubio, Virginia Calvo, Amelia Insa, Santiago Ponce, Noemı́ Reguart, Javier de Castro, Joaquín Mosquera, Manuel Cobo, Andrés Aguilar, Guillermo López-Vivanco, Carlos Camps, Rafael López Castro, Teresa Morán, I. Barneto, Delvys Rodríguez‐Abreu, Roberto Serna‐Blasco, Raquel Benítez, Carlos Aguado, Ramón Palmero, Florentino Hernándo, Javier Martín-López, Alberto Cruz‐Bermúdez, Bartomeu Massutí, Atocha Romero - New England Journal of Medicine 2023 被引用: 450

  2. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

    著者: Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares - The Lancet Oncology 2012 被引用: 5,530

  3. Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer

    著者: Jürgen Wolf, Takashi Seto, Ji‐Youn Han, Noemı́ Reguart, Edward B. Garon, Harry J.M. Groen, Daniel S.W. Tan, Toyoaki Hida, Maja J.A. de Jonge, Sergey Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Maximilian J. Hochmair, Enriqueta Felip, Makoto Nishio, Michael Thomas, Kadoaki Ohashi, Ryo Toyozawa, Tobias R. Overbeck, Filippo de Marinis, Tae Min Kim, Eckart Laack, Anna Robeva, Sylvie Le Mouhaër, Maeve Waldron-Lynch, B. Sankaran, O. Alejandro Balbin, Xiaoming Cui, Monica Giovannini, Mikhail Akimov, Rebecca S. Heist - New England Journal of Medicine 2020 被引用: 997

  4. Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

    著者: Luis Paz‐Ares, Stéphane Champiat, W. Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa L. Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemı́ Reguart, Tatsuya Yoshida, Kai He, Shirish M. Gadgeel, Enriqueta Felip, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek K. Owonikoko - Journal of Clinical Oncology 2023 被引用: 294

  5. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    著者: Anne‐Marie C. Dingemans, Martin Früh, Andrea Ardizzoni, Benjamin Besse, Corinne Faivre‐Finn, Lizza Hendriks, Sylvie Lantuéjoul, Solange Peters, Noemı́ Reguart, Charles M. Rudin, Dirk De Ruysscher, Paul Van Schil, Johan Vansteenkiste, Martin Reck - Annals of Oncology 2021 被引用: 574

  6. Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

    著者: Fiona Blackhall, Kevin Jao, Laurent Greillier, Byoung Chul Cho, Konstantin Penkov, Noemı́ Reguart, Margarita Majem, Kristiaan Nackaerts, Konstantinos Syrigos, Karin Holmskov Hansen, Wolfgang Schuette, Jeremy Cetnar, Federico Cappuzzo, Isamu Okamoto, Mustafa Erman, Seppo W. Langer, Terufumi Kato, Harry J.M. Groen, Zhaowen Sun, Yan Luo, Poonam Tanwani, L. Caffrey, Philip Komarnitsky, Niels Reinmuth - Journal of Thoracic Oncology 2021 被引用: 258

  7. Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

    著者: Rafael Rosell, Teresa Morán, Cristina Queralt, Rut Porta, Felipe Cardenal, Carlos Camps, Margarita Majem, Guillermo López-Vivanco, Dolores Isla, Mariano Provencio, Amelia Insa, Bartomeu Massutí, J.L. González-Larriba, Luis Paz‐Ares, Isabel Bover, Rosario García‐Campelo, Miguel Ángel Moreno, Sílvia Catot, Christian Rolfo, Noemı́ Reguart, Ramón Palmero, José Miguel Sánchez, Roman Bastus, Clara Mayo, Jordi Bertran-Alamillo, Miguel Ángel Molina‐Vila, José Javier Sánchez, Miquel Tarón - New England Journal of Medicine 2009 被引用: 2,377

  8. Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer

    著者: Salma K. Jabbour, Ki Hyeong Lee, Nikolaj Frost, В. В. Бредер, Dariusz M. Kowalski, Theodore Pollock, E. Levchenko, Noemı́ Reguart, Alex Martínez‐Martí, Baerin Houghton, Jean-Baptiste Paoli, Sufia Safina, Keunchil Park, Takefumi Komiya, Amy Sanford, Vishal Boolell, Hong Liu, Ayman Samkari, Steven M. Keller, Martin Reck - JAMA Oncology 2021 被引用: 255

  9. Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

    著者: Aleix Prat, Alejandro Navarro, Laia Paré, Noemı́ Reguart, Patricia Galván, Tomás Pascual, Alex Martínez‐Martí, Paolo Nucíforo, Laura Comerma, Llúcia Alós, Núria Pardo, S. Cedrés, Cheng Fan, Joel S. Parker, Lydia Gaba, Iván Victoria, Núria Viñolas, Ana Vivancos, Ana Arance, Enriqueta Felip - Cancer Research 2017 被引用: 477

  10. Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial

    著者: Jordi Remón, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, K. Al-Rabi, Reyes Bernabé, L. Greillier, Margarita Majem, Noemı́ Reguart, I. Monnet, S. Cousin, Pilar Garrido, G. Robinet, Rosario García Campelo, A. Madroszyk, Julien Mazières, H. Curcio, Bartosz Wasąg, Y. Pretzenbacher, B. Fournier, Anne‐Marie C. Dingemans, Rafał Dziadziuszko - Annals of Oncology 2023 被引用: 73

  11. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

    著者: M. Duruisseaux, Anna Martínez‐Cardús, María Eréndira Calleja-Cervantes, Sebastián Morán, Manuel Castro de Moura, Verónica Dávalos, David Piñeyro, Montse Sánchez‐Céspedes, Nicolas Girard, Marie Brevet, Etienne Giroux‐Leprieur, Coraline Duménil, Monica Pradotto, Paolo Bironzo, Enrica Capelletto, Silvia Novello, Alexis B. Cortot, Marie‐Christine Copin, Niki Karachaliou, María González‐Cao, Sergio Peralta, Luis M. Montuenga, Ignacio Gil‐Bazo, Iosune Baraibar, María D. Lozano, Mar Varela, J.C. Ruffinelli, Ramón Palmero, Ernest Nadal, Teresa Morán, L.Mezquita Pérez, Immaculada Ramos, Qingyang Xiao, Agustín F. Fernández, Mario F. Fraga, Marta Gut, Marta Gut, Cristina Teixidó, Noelia Vilariño, Aleix Prat, Noemı́ Reguart, Amparo Benito, Pilar Garrido, Isabel Barragán, Jean‐François Emile, Rafael Rosell, Élisabeth Brambilla, Manel Esteller - The Lancet Respiratory Medicine 2018 被引用: 222

  12. Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial

    著者: Jürgen Wolf, Maximilian J. Hochmair, Ji‐Youn Han, Noemı́ Reguart, Pierre‐Jean Souquet, Egbert F. Smit, Sergey Orlov, Johan Vansteenkiste, Makoto Nishio, Maja J.A. de Jonge, Wallace Akerley, Edward B. Garon, Harry J.M. Groen, Daniel S.W. Tan, Takashi Seto, Garrett M. Frampton, Anna Robeva, Mariana Carbini, Sylvie Le Mouhaër, A. Yovine, Aislyn Boran, Claudia Bossen, Yiqun Yang, Lexiang Ji, Lauren Fairchild, Rebecca S. Heist - The Lancet Oncology 2024 被引用: 64

  13. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

    著者: Imane Chaib, Niki Karachaliou, Sara Pilotto, Jordi Codony Servat, Xueting Cai, Xuefei Li, Ana Drozdowskyj, Carles Codony, Jie Yang, Chunping Hu, Andrés F. Cardona, Guillermo López-Vivanco, A. Vergnenègre, José Miguel Sánchez, Mariano Provencio, Filippo de Marinis, Antonio Passaro, Enric Carcereny, Noemı́ Reguart, Charo Garcia Campelo, Cristina Teixidó, Isabella Sperduti, Sónia Rodríguez, Chiara Lazzari, Alberto Verlicchi, Itziar de Aguirre, Cristina Queralt, Jia Wei, Roger Estrada, Raimon Puig de la Bellacasa, José Luis Ramírez, Kirstine Jacobsen, Henrik J. Ditzel, Mariacarmela Santarpía, Santiago Viteri, Miguel Ángel Molina‐Vila, Caicun Zhou, Peng Cao, C. Patrick, Trever G. Bivona, Rafael Rosell - JNCI Journal of the National Cancer Institute 2017 被引用: 216

  14. MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence

    著者: Marta Gabasa, Evette S. Radisky, Rafael Ikemori, Giulia Bertolini, Marselina Arshakyan, Alexandra Hockla, Paula Duch, Ornella Rondinone, Alejandro Llorente, María Maqueda, Albert R. Davalos, Elena Gavilán, Alexandre Perera-Lluna, José Ramírez, Pere Gascón, Noemı́ Reguart, Luca Roz, Derek C. Radisky, Jordi Alcaraz - Cancer Letters 2021 被引用: 60

  15. Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer

    著者: Rafael Molina, Ramón M. Marrades, Josep M. Augé, José Miguel Escudero Fernández, Núria Viñolas, Noemı́ Reguart, José Ramírez, Xavier Filella, Laureano Molins, Àlvar Agustí - American Journal of Respiratory and Critical Care Medicine 2015 被引用: 189

  16. Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective

    著者: Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, Ronald Damhuis, Noemı́ Reguart, Mariano Provencio, Antonin Lévy, Rafał Dziadziuszko, Cecilia Pompili, Massimo Di Maïo, Michael Thomas, Alessandro Brunelli, Sanjay Popat, Suresh Senan, Idris Bahce - The Lancet Regional Health - Europe 2024 被引用: 35

  17. OA06.05 Consensual Definition of Stage III NSCLC Resectability: EORTC-Lung Cancer Group Initiative with Other Scientific Societies

    著者: Anne‐Marie C. Dingemans, Jordi Remón, Lizza Hendriks, John Edwards, Corinne Faivre‐Finn, Noemı́ Reguart, Egbert F. Smit, Antonin Lévy, David Sánchez-Lorente, Juan Trujillo, Andrea Riccardo Filippi, K. Stathopoulos, Torsten Blum, Matthias Gückenberger, Sanjay Popat, I. Opitz, Alessandro Brunelli, Roberta De Angelis, Paul Hofman, Koen J. Hartemink, R. Horsleben, E. Ruffine, Chris Dickhoff, Elena Prisciandaro, Jules L. Derks, Idris Bahce, Alessio Vincenzo Mariolo, Eleni Xenophontos, N. Giaj Levra, Ilias Houda, Mariana Brandão, Thierry Berghmans - Journal of Thoracic Oncology 2023 被引用: 25

  18. Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions

    著者: Sergi Villatoro, Clara Mayo‐de‐las‐Casas, Núria Jordana‐Ariza, Santiago Viteri, Mónica Garzón‐Ibáñez, Irene Moya‐Horno, Beatriz García‐Peláez, María González‐Cao, Umberto Malapelle, Ariadna Balada‐Bel, Alejandro Martínez‐Bueno, Raquel Munhoz da Silveira Campos, Noemı́ Reguart, Margarita Majem, Remei Blanco, Ana Blasco, María José Catalán, Xavier González, Giancarlo Troncone, Niki Karachaliou, Rafael Rosell, Miguel Ángel Molina‐Vila - Molecular Oncology 2019 被引用: 84

  19. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma

    著者: Paula Duch, Natalia Díaz‐Valdivia, Rafael Ikemori, Marta Gabasa, Evette S. Radisky, Marselina Arshakyan, Sabrina Gea‐Sorlí, Anna Mateu-Bosch, Paloma Bragado, Josep L. Carrasco, Hidetoshi Mori, José Ramírez, Cristina Teixidó, Noemı́ Reguart, Cristina Fillat, Derek C. Radisky, Jordi Alcaraz - Matrix Biology 2022 被引用: 42

  20. Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non–Small-Cell Lung Cancer

    著者: Jordi Remón, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabé, Laurent Greillier, Margarita Majem, Noemı́ Reguart, I. Monnet, Sophie Cousin, Pilar Garrido, G. Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazières, Hubert Curcio, Bartosz Wasąg, Yassin Pretzenbacher, Fanny Grillet, Anne‐Marie C. Dingemans, Rafał Dziadziuszko - Journal of Clinical Oncology 2024 被引用: 31

  21. Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts

    著者: Miguel Vizoso, Marta Puig, F. Javier Carmona, María Maqueda, Adriana Velásquez, Antonio Gómez, Anna Labernadie, Roberto Lugo, Marta Gabasa, Luis G. Rigat-Brugarolas, Xavier Trepat, José Ramírez, Sebastián Morán, Enrique Vidal, Noemı́ Reguart, Alexandre Perera, Manel Esteller, Jordi Alcaraz - Carcinogenesis 2015 被引用: 110

  22. Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types

    著者: Laia Paré, Tomás Pascual, Elia Seguí, Cristina Teixidó, María González‐Cao, Patricia Galván, A. Rodríguez, Blanca González‐Farré, Míriam Cuatrecasas, Estela Pineda, Aureli Torné, Guillermo Crespo, Salvador Martín‐Algarra, Elísabeth Pérez-Ruiz, Òscar Reig, Margarita Viladot, Carme Font, Bárbara Adamo, María Vidal, Lydia Gaba, Montserrat Muñoz-Mateu, Iván Victoria, Guillermo Mora Ruiz, Núria Viñolas, Begoña Mellado, Joan Maurel, Javier García-Corbacho, Miguel Ángel Molina‐Vila, Manel Juan, Josep M. Llovet, Noemı́ Reguart, Ana Arance, Aleix Prat - Annals of Oncology 2018 被引用: 99

  23. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

    著者: Eva Pros, Maria Saigí, Daniel Alameda, Gema Gómez‐Mariano, Beatriz Martínez–Delgado, Juan J. Alburquerque-Béjar, Julián Carretero, Raúl Tonda, Anna Esteve‐Codina, I. Català, Ramón Palmero, Maria Jové, Conxi Lázaro, Ana Patiño‐García, Ignacio Gil‐Bazo, Sara Verdura, Àlex Teulé, Juan Torres‐Lanzas, David Sidransky, Noemı́ Reguart, Rubén Pı́o, Óscar Juan, Ernest Nadal, Enriqueta Felip, Luis M. Montuenga, Montse Sánchez‐Céspedes - Annals of Oncology 2020 被引用: 56

  24. New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe

    著者: Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, Noemı́ Reguart, Mariano Provencio, Antonin Lévy, Rafał Dziadziuszko, Cecilia Pompili, Massimo Di Maïo, Michael L. Thomas, Alessandro Brunelli, Sanjay Popat, Suresh Senan, Idris Bahce - The Lancet Regional Health - Europe 2024 被引用: 31